-transparent.png){kind=logo}
Recently, the relative contributions of local T helper cell responses of the Th1-type and Th2-type to the pathogenesis of gastritis and peptic ulcers associated with Helicobacter pylori infection have been examined. However, the results were controversial with respect to whether cellular immunity (Th1-type) or humoral immunity (Th2-type) responses predominate in H. pylori infection and with respect to how these responses may contribute to disease pathogenesis. In this study, we investigated the characteristics of the production of various cytokines induced by H. pylori or lipopolysaccharide (LPS), which was derived from H. pylori or Escherichia coli, in human peripheral blood mononuclear cells (PBMC). Live H. pylori induced production of many cytokines, such as IL-1beta, IL-10, IL-8, IFN-gamma, and TNF-alpha, whereas we could not detect IL-2 or IL-4. Moreover, we evaluated the effect of rebamipide on the production of several cytokines from PBMC induced by various stimuli. Rebamipide suppressed the production of IL-8, IL-10, TNF-alpha, and IL-1beta induced by H. pylori in a dose-dependent manner. On the other hand, the production of IL-12 induced by H. pylori showed a tendency to increase as a result of treatment of the cells with rebamipide. These results suggested that rebamipide might be effective in regulating cytokine responses in the H. pylori-infected host and maintaining host immunity. Moreover, it might contribute positively to disease progression and bacterial eradication.
M Aihara, and
K Imagawa, and
Y Funakoshi, and
Y Ohmoto, and
M Kikuchi
April 2002,
Chudoku kenkyu : Chudoku Kenkyukai jun kikanshi = The Japanese journal of toxicology,
M Aihara, and
K Imagawa, and
Y Funakoshi, and
Y Ohmoto, and
M Kikuchi
October 1992,
Rinsho byori. The Japanese journal of clinical pathology,
M Aihara, and
K Imagawa, and
Y Funakoshi, and
Y Ohmoto, and
M Kikuchi
January 1991,
Clinical therapeutics,
M Aihara, and
K Imagawa, and
Y Funakoshi, and
Y Ohmoto, and
M Kikuchi
December 1996,
Journal of dairy science,
M Aihara, and
K Imagawa, and
Y Funakoshi, and
Y Ohmoto, and
M Kikuchi
December 2003,
Antimicrobial agents and chemotherapy,
M Aihara, and
K Imagawa, and
Y Funakoshi, and
Y Ohmoto, and
M Kikuchi
February 2009,
Life sciences,
M Aihara, and
K Imagawa, and
Y Funakoshi, and
Y Ohmoto, and
M Kikuchi
February 1995,
Immunology letters,
M Aihara, and
K Imagawa, and
Y Funakoshi, and
Y Ohmoto, and
M Kikuchi
January 1992,
Microbiology and immunology,
M Aihara, and
K Imagawa, and
Y Funakoshi, and
Y Ohmoto, and
M Kikuchi
May 2001,
Annals of the Academy of Medicine, Singapore,
M Aihara, and
K Imagawa, and
Y Funakoshi, and
Y Ohmoto, and
M Kikuchi
January 2008,
Microbiological research,
